Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT06935864
Recruiting
Tissue Expression of Krüppel-Like Factors 4 and 7 in Bone Tumors
Not applicable · Egypt · 2 sites
Registry update: 20 Apr 2025
NCT06395103
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Phase 1/2 · Australia, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Germany, Denmark, Spain, France, United Kingdom, Greece, Hungary, Israel, Italy, South Korea, Netherlands, Sweden, Slovakia, Taiwan, United States · 72 sites
Registry update: 30 Oct 2026
NCT06531486
Recruiting
A Phase I Study of XS-02 Capsules in Patients With Advanced Solid Tumors
Phase 1 · China · 1 site
Registry update: 26 Oct 2026
NCT06829654
Recruiting
Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors
Not applicable · Italy · 1 site
Registry update: 17 Feb 2025
NCT06506838
Recruiting
Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma
Phase 4 · China · 1 site
Registry update: 12 Aug 2024
NCT06333314
Recruiting
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
Phase 2 · France · 22 sites
Registry update: 2 Dec 2025
NCT06440005
Recruiting
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Phase 1 · United States · 7 sites
Registry update: 9 Sept 2026
NCT06500819
Recruiting
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
Phase 1 · United States · 1 site
Registry update: 7 May 2026
NCT05907759
Recruiting
Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
Phase 2 · United States · 1 site
Registry update: 16 Oct 2026
NCT06875700
Recruiting
Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
Not applicable · United States · 1 site
Registry update: 13 Jun 2025
NCT06514313
Recruiting
Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.
Phase 2 · China · 1 site
Registry update: 23 Jul 2024
NCT06263231
Recruiting
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
Phase 3 · Canada, Germany, Spain, France, Italy, Poland, United States · 41 sites
Registry update: 11 Aug 2026
NCT06389799
Recruiting
A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
Phase 2 · Norway, Sweden · 4 sites
Registry update: 27 Aug 2026
NCT06749600
Recruiting
Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma
Not applicable · Italy · 10 sites
Registry update: 5 May 2026
NCT06456892
Recruiting
Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen
Phase 1/2 · China · 1 site
Registry update: 13 Jun 2024
NCT06436612
Recruiting
Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)
Phase 2 · United States · 1 site
Registry update: 5 Jun 2026
NCT06211257
Recruiting
Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment.
Not applicable · France · 11 sites
Registry update: 18 Mar 2026
NCT04715191
Recruiting
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Phase 1 · United States · 1 site
Registry update: 6 Aug 2026
NCT06345729
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Phase 3 · Argentina, Austria, Australia, Bulgaria, Brazil, Canada, Chile, China, Colombia, Costa Rica, Germany, Spain, France, United Kingdom, Georgia, Greece, India, Italy, Japan, South Korea, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Romania, Ukraine, United States · 247 sites
Registry update: 26 Oct 2026
NCT05131386
Recruiting
Clinical trial of trabectedin, irinotecann and low-dose radiation therapy in advanced/metastatic sarcomas.
Phase 2 · Spain · 8 sites
Registry update: 8 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.